Table 3.
Zanubrutinib concentrations in plasma and CSF.
Interval between administration and sampling | Sample | Mean concentration(pg/ml) | P-value | |
---|---|---|---|---|
Plasma | 2 h | 10 | 182909.3 ± 91077.1 | 0.193 |
3 h | 13 | 125813.7 ± 91605.7 | ||
entire series | 23 | 143190.6 ± 93302.7 | ||
CSF | 2 h | 10 | 4117.0 ± 2864.3 | 0.192 |
3 h | 13 | 2426.6 ± 2028.0 | ||
entire series | 23 | 2941.1 ± 2382.01 | ||
Corrected CSF/plasma ratio (%) | 2 h | 10 | 41.2 ± 32.5 | 0.869 |
3 h | 13 | 43.3 ± 26.5 | ||
entire series | 23 | 42.7 ± 27.7 |